Introduction
The G protein-coupled receptor (GPCR) family mediates a variety of signal transduction pathways in living organisms and its signaling mechanism has been well studied in the past several decades. Recently, a number of novel binding partners of G protein subunits have been reported as additional regulators to the classic mechanism of GPCR signaling. One particular group of these modulators is the activator of G protein signaling (AGS) family. AGS members were first identified in a functional screen for activators of heterotrimeric G proteins in Saccharomyces cerevisiae [1, 2] . The screen allowed rapid identification of proteins that activate the G ␤ ␥ -mediated pheromone response pathway in S. cerevisiae in the absence of a pheromone-responsive GPCR [1] .
AGS family members activate the G protein pathways in a receptor-independent manner. Most of the family members are distinct proteins that lack structural homology between them. They are classified into three distinct groups based on their activation mechanism in the S. cerevisiae -based functional screen [3] . Group I contains AGS1 which activates G protein signaling by acting as a guanine nucleotide exchange factor (GEF) for G ␣ i/o and promotes the binding of GTP ␥ S to G ␣ i2 as well as puri-fied brain G ␣ proteins [1, 4] . Group II members include AGS3 to AGS6 and they activate G protein signaling by interacting with G ␣ i -GDP in the absence of nucleotide exchange. AGS3-6 possess at least one G protein regulatory (GPR) motif, a conserved 25-30 amino acid sequence responsible for interacting with GDP-bound G ␣ i/o subunits. They are known as guanine nucleotide dissociation inhibitors (GDIs) because of their inhibitory effect on GDP dissociation from G ␣ i subunits [5] . The GDIs stabilize the G ␣ i subunits in the GDP-bound state and lead to three possible outcomes: (1) Activation of G ␤ ␥ signaling by AGS proteins competing against G ␤ ␥ for G ␣ i -GDP from the pool of heterotrimeric complexes and triggering release of G ␤ ␥ subunits for downstream signals; or (2) AGS/G ␣ i -GDP complex acting as a signaling molecule having specific downstream effectors; or (3) AGS/G ␣ i -GDP complex acting as a substrate for GEF to generate G ␣ i -GTP. Group III AGS is composed of AGS2, AGS7 to AGS10. The criterion for inclusion in this group is activating G protein signaling via direct interaction with G ␤ ␥ subunits. AGS2 and AGS8 have been reported to interact with G ␤ ␥ [2, 6] and the interaction of AGS7 with G ␤ ␥ has been mentioned as unpublished data [7] . AGS10 encodes G ␣ o which is known to be a good binding partner of G ␤ ␥ . In contrast, AGS9 has not yet been demonstrated as an interacting partner of G ␤ ␥ . AGS9 and AGS10 are classified into Group III because their properties in the yeast screen are similar to AGS2, AGS7 and AGS8 [8] .
Since AGS proteins can activate G proteins in a receptor-independent manner, they have the potential to regulate the majority of GPCR-mediated neuronal signaling pathways. Neuronal functions that have been reported to be regulated by AGS members are summarized in table 1 and the roles of AGS proteins will be discussed according to their regulatory functions in the nervous system. A number of excellent reviews are available for a more comprehensive analysis of the mechanistic pathway and structural properties of AGS proteins [3, [7] [8] [9] [10] [11] .
Regulation of Circadian Rhythm via AGS1
AGS1 is also named as Dexras1 , a dexamethasone-inducible, ras-related protein in AtT20 cells [12] or RASD1 by the HUGO Gene Nomenclature Committee. It activates the G ␤ ␥ -mediated yeast pheromone response pathway in the absence of GPCR [1] by serving as a GEF of G ␣ i [4] . AGS1 also belongs to the Ras family and contains all consensus guanine nucleotide binding regions of Ras proteins [4] . It has been suggested that guanine nucleotide binding to AGS1 is required for its proper functioning [4] . AGS1 is widely expressed in the nervous system with rhythmic expression in suprachiasmatic nucleus (SCN) [13] , the protein distribution pattern of AGS1 in the central nervous system (CNS) is summarized in table 2 . AGS1 is regulated by the NMDA receptor and neuronal nitric oxide synthase (nNOS) [14] and it has been reported to play a role in circadian rhythm [15, 16] .
Since the discovery of AGS1, the mechanisms underlying its regulation and signal transduction have been extensively studied. A yeast two-hybrid study screening a cDNA library of rat hippocampus and cortex against the phosphotyrosine-binding (PTB) domain of CAPON (carboxy-terminal PDZ ligand of nNOS), a nNOS adaptor protein, has identified a fragment of rat AGS1 (amino acids 235-280) [14] . The C-terminus of AGS1 is found to interact with the N-terminal PTB domain of CAPON to form a ternary complex with CAPON and nNOS. Upon interaction, AGS1 is S-nitrosylated by NO donors at cys- [17] and is associated with elevated GTP binding on AGS1 as well as GEF activity [14] . The nNOS-mediated activation of AGS1 is hugely enhanced by the co-transfection of CAPON. In contrast, the GEF activity of AGS1 is reduced in nNOS -/-mice [14] . Since the NMDA receptor stimulates nNOS activation [18] , it has been suggested that AGS1 is activated by NMDA receptor-mediated NO synthesis with CAPON as an adaptor protein that brings AGS1 and nNOS into juxtaposition ( fig. 1 ) . Subsequently, the activated AGS1 facilitates guanine nucleotide exchange on G ␣ i [14] and regulates expression of immediate-early genes, such as c-Fos, JunB and EGR-1, as well as CRE-dependent transcription via MAPK pathway [19] ( fig. 1 , 2 ) .
AGS1 has been identified as a circadian rhythm related gene with its expression in the SCN altering in a circadian rhythmic manner [13] . The expression of ags1 in thalamus, piriform cortex and hippocampus, however, is not rhythmic. The AGS1 gene expression in SCN is minimized and maximized at zeitgeber time (ZT) 2 and 14, respectively, with approximately five-fold difference. In cryptochrome1 (cry1) and cryptochrome2 (cry2) double knock-out mice, the rhythmic gene expression of AGS1 is abolished [13] . These observations suggest the involvement of AGS1 in circadian rhythm.
The generation of dexras1 -/-mice [15] has revealed a role of AGS1 in gating the photic and non-photic stimuli for circadian entrainment. The photic phase response curve indicates dexras1 -/-mice have robust phase advances in the middle of the daytime (ZT8) and at late subjective night (ZT20) in response to the light pulses, whereas the wild-type mice do not [16] . The dexras1 -/-mice cannot induce phase delays in response to light at early subjective night (ZT14) [15, 16] , and they also exhibit increased sensitivity to non-photic stimuli as compared to the wildtype [15] . The normal regulation of external stimuli entrainment in dexras1 -/-mice is completely disrupted and has responses opposite to the wild-type. The differently modulated MAPK/ERK pathway in the dexras1 -/-mice at different ZT is considered as the cause of altered sensitivity of the circadian clock to light. At ZT14, light-induced ERK activation in the SCN is attenuated in the dexras1 -/-mice [15] , whereas at late ZT20 a significantly higher ERK phosphorylation level than the wild-type in response to light exposure is noted [16] . Moreover, light-induced phosphorylated ERK level at ZT8 is increased in dexras1 -/-mice but not in wild-type mice [16] . To sum up, AGS1 is responsible for enhancing A proposed model of photic responsiveness regulation of the circadian clock at different ZT by AGS1. At ZT8, the lightinduced phase advance in dexras1 -/-mice indicates the importance of AGS1 gating the light input to the circadian clock. The effect of AGS1 is mediated by MAPK pathway inhibition but the exact mechanism remains unclear. At ZT14, photic stimuli activate AGS1 via the NMDA receptor and modulate clock genes expression in a MAPK-dependent pathway. At ZT20, the light responsiveness of the circadian clock is regulated by PAC1 receptor. The activation of PAC1 receptor releases G ␣ s and G ␤ ␥ , which stimulate adenylyl cyclases and increase cAMP level. The PAC1-mediated pathway is considered to be inhibited by the light-induced G ␣ i -GTP via AGS1.
Color version available online Fig. 1 . Putative photic and nonphotic pathways of the circadian clock. In the photic pathway, light stimuli act through the NMDA receptors in the SCN and activate AGS1. The activated AGS1 facilitates exchange of GDP for GTP on G ␣ i via its GEF activity leading to the regulation of a set of clock genes for circadian clock control. In the nonphotic pathway, the nonphotic stimuli are mediated by the NPY receptor in the SCN. The nonphotic pathway is inhibited by the photic pathway through AGS1 which competes against the NPY receptor for a common pool of G ␣ i -GDP. Arrow with solid line = activation; arrow with dotted line = activation through intermediates; two arrows pointing to opposite directions = competition. the light-induced ERK phosphorylation at ZT14 and, conversely, suppresses the activation of ERK at ZT8 and ZT20 in the wild-type mice. This observation can be linked to the rhythmically expressed AGS1 in SCN. The AGS1 level in SCN is maximal at ZT14 but is relatively low at ZT8 and ZT20 [13] .
Although the responsiveness of the circadian clock to light is also influenced by other rhythmically expressed proteins, such as the NMDA receptor channel subunits epsilon 3 and zeta 1 [20] , the expression profile of AGS1 plays a major part in gating the light input to the circadian clock. How does altering the expression level of AGS1 generate different responses to light? This is one of the key questions to unlock the role of AGS1 in the control of circadian rhythm. The phase delay of the wild-type mice at ZT14 is presumably caused by the activation of NMDA receptors ( fig. 2 ). Infusion of MEK1/2 inhibitor (U1026) inhibits the phase delay of both genotypes [15] . Interestingly, pertussis toxin (PTX) treatment significantly reduces the level of NMDA-induced phase shifting of wild-type animals to the level of dexras1 -/-mice, while having no effect on dexras1 -/-mice [15] . It implies that G ␣ i/o signaling is involved in the photic entrainment at ZT14 and is perhaps modulated by the GEF activity of AGS1. It has also been suggested that light exposure at ZT14 stimulates the NMDA receptor and activates AGS1 by S-nitrosylation via the nNOS/CAPON/AGS1 complex [14] ( fig. 1 ) . Activated AGS1 may then facilitate the exchange of GDP for GTP on G ␣ i proteins and induce downstream signals, including the MAPK pathway. The activated MAPK pathway in turn modulates the behavioral phase shifts and transcription of genes [19] .
The responses of circadian clock to light at ZT20 are regulated by G s -linked pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor (PAC1) [16, 21] ( fig. 2 ). PACAP 6-38, a potent antagonist of PAC, and U0126 block the phase advances [16] . Overexpression of AGS1 or a G ␤ ␥ scavenger, the C-terminus of ␤ -adrenergic receptor kinase ( ␤ ARK-ct), reduces the PACAP-induced Elk1 transactivation by over 55%, as compared to the control [16] . In addition, dexras1 -/-mice have higher cAMP basal levels at ZT20 as compared to the wild-type mice, and photic stimuli can further stimulate the cAMP production in dexras1 -/-mice [16] . It has been hypothesized that the stimulation of NMDA receptor by light activates AGS1 and promotes the formation of G ␣ i -GTP which may subsequently inhibit G s -coupled pathways [16] .
The mechanism of the light-induced phase advance in the dexras1 -/-mice at ZT8 remains unclear [16] . The phase advance can be abolished by U0126 infusion indicating that the phase shift is mediated by an ERK-dependent pathway [16] . As nocturnal rodents do not respond to photic stimuli during daytime at both behavioral and cellular levels [22] , the light-induced phase advance at ZT8 in the dexras1 -/-mice further confirms the importance of AGS1 in gating the light input to the circadian clock. Successful identification of interacting partners of AGS1 at ZT8 might explain how AGS1 controls the sensitivity of the circadian rhythm to light at daytime in rodents.
The regulation of nonphotic stimuli by AGS1 has been unmasked by studying the antagonistic effect of neuropeptide Y (NPY), a neurotransmitter involved in nonphotic-like effects [23] , on NMDA-induced phase shifts. The NMDA-mediated phase shift in dexras1 -/-mice SCN neurons are more sensitive to NPY antagonistic effect than wild-type mice, and such effect can be reverted by PTX treatment [14] . The inhibitory effect of AGS1 on NPY receptor-mediated signaling is possibly caused by AGS1 competing for a common pool of G ␣ i -GDP against NPY receptor [15] , and it may apply to other G ␣ i -mediated signaling with a mechanism depicted in figure 1 .
Since AGS1 activates G ␣ i , it may affect G i -coupled receptors which play a role in circadian rhythm. For instance, melatonin MT 1 and MT 2 receptors [24] are potential targets of AGS1. Other circadian rhythm-related G icoupled receptors include 5-hydroxytryptamine (5-HT 1B and 5-HT 5A ) [25, 26] , dopamine (D 2 and D 3 ) [27] , GABA (GABA B ) [28] , prokineticin 2 [29] and prostanoid EP 1 [30] receptors. Although not all of these receptors are expressed in the SCN, they are co-expressed with AGS1 in one or more regions of the nervous system and therefore may be regulated by AGS1. If so, AGS1 may also participate in diseases involving these receptors, such as Parkinson's disease, Alzheimer's disease and schizophrenia.
Development and Maintenance of Drug Addiction by AGS3
AGS3 has been reported as a protein involved in multiple processes including addiction [31] [32] [33] [34] , aggresomal pathway [35] , asymmetric cell division [36] , cardiovascular function [37] , cell proliferation [38] , macroautophagy [39] , membrane protein trafficking [40] and metabolism [37] . Among these biological adaptations, the roles of AGS3 in the CNS regulating drug addiction and asymmetric cell division are discussed in this review. AGS3 is broadly distributed in the CNS, with its function remain- ing unknown in most of the brain regions. It is a GDI which actively competes against G ␤ ␥ subunits for G ␣ i -GDP subunit [5, 41] . AGS3 can actively uncouple G ␣ i -GDP subunits from G i -coupled receptors [41] and presumably leads to attenuation of G ␣ i signaling and augmentation of G ␤ ␥ signaling as illustrated in figure 3 .
Drug addiction is a neuropathological disorder caused by the repeated administration of drugs. The mechanisms of its development remain unclear, and may vary for different drugs. In recent studies, AGS3 expression level has been found to be up-regulated in the prefrontal cortex (PFC) and/or nucleus accumbens core (NAcore) in response to cocaine withdrawal [31] . This finding has spurred a new inspiration to understand drug addiction, with the idea that AGS3 may represent a core component in the development of drug addiction. The AGS3 protein level is increased in certain animal models of drug addiction. In cocaine relapse, AGS3 is upregulated in rat NAcore and PFC 3 weeks after cocaine withdrawal and remains so for 8 weeks [31] . In ethanol addiction, AGS3 is up-regulated in NAcore 3 weeks after abstinence without any change of AGS3 level in other nuclei related to the rewarding systems (e.g. PFC and dorsal striatum) [32] . Similar AGS3 up-regulation is also reported in NAcore/ striatal neurons after 5 h abstinence of chronic morphine treatment [33] . Although there is no report on chronic heroin administration upregulating AGS3 in the brain regions, knock-down of AGS3 has been shown to eliminate heroin-seeking behavior in rats [34] .
The AGS3 expression profile has been considered as a control switch in drug addiction; however, there is no indication as to how AGS3 expression level is regulated. AGS3 is found to be coregulated with USP9x (ubiquitin specific protease 9x) in the rat PFC after cocaine withdrawal [42] . USP9x interacts with the GPR motifs of AGS3 and stabilizes AGS3 by de-ubiquitination 
On the other hand, the activation of G ␤ ␥ signaling by up-regulated AGS3 can regulate a series of transcription factors, such as members of the STAT family. This hypothesis correlates with our recent demonstration that several G ␤ ␥ subunits containing the neuronal-specific G ␥ 2 , G ␥ 4 , G ␥ 7 and G ␥ 9 can induce phosphorylation of STAT1 and STAT3 [43] . The activated G ␤ ␥ signaling may positively feedback to enhance the production of AGS3 by inducing transcription via STAT1/STAT3, although the existence of transcription factor-binding sites for STAT1/STAT3 on the AGS3 promoter sequence is yet to be studied. Therefore, the expression level of AGS3 is possibly controlled at both transcription and post-translational levels.
There are a number of reports describing altered G protein kinetics and stoichiometry in cocaine [44] , heroin [45] , and alcohol [46] addiction models. It is therefore of particular interest to study the role of AGS3 in different addiction models. The G ␣ i signaling is reduced in PFC upon AGS3 upregulation during cocaine abstinence [31] . In contrast, AGS3 knock-down recovers the altered G ␣ i signaling and stops drug seeking behavior [31] . There is no direct evidence, thus far, to demonstrate that up-regulated AGS3 can modulate G ␣ i or G ␤ ␥ signaling in other addiction models (e.g., heroin and ethanol). However, the sequestration of G ␤ ␥ subunit by ␤ ARK1 has been shown to have the same effect as the knock-down of AGS3 for both heroin [34] and ethanol [32] addictions, suggesting that AGS3 and G ␤ ␥ may exist in the same signaling pathway and the G ␤ ␥ -mediated signaling could be enhanced by the up-regulated AGS3 via stabilization of G ␣ i -GDP.
Some downstream effectors of G ␤ ␥ subunits such as adenylyl cyclases (ACs) 2 and 4 have been reported to be required in -opioid receptor (MOR) signaling. The knock-down of AC2 or AC4 abolishes the MOR-mediat- [34] . Interestingly, AC super-activaton induced by morphine withdrawal does not require G ␤ ␥ function because ␤ ARK1 has no effect on it [33] . Moreover, the cAMP super-activation by morphine withdrawal requires AGS3, AC5 and AC7 [33] but not AC2 or AC4. These observations further demonstrate that AGS3 is required in the development of different types of drug addiction. However, the signaling pathways involved appear to be different. We have previously demonstrated that multiple G proteins and signaling components participate in opioid receptor-mediated AC super-activation [47] [48] [49] [50] [51] [52] , and our recent focus is on the effect of AGS3 on -opioid-induced AC super-activation. Overexpression of full length or the GPR motif of AGS3 is unable to mimick or enhance the AC super-activation in HEK293. In contrast, our data suggests that the GPR motif of AGS3 reduces the -opioid receptor-mediated AC super-activation ( fig. 4 ). This is supported by previous literature wherein AGS3S inhibits the sensitization of G s -mediated AC signals in CHO cells [53] . The differences among these observations could be explained by the different complements of G protein subunits and/or AC isoforms present in the various cellular models.
The majority of studies on AGS3 signaling have been focused on the enhancement of G ␤ ␥ signaling and the inhibition of G ␣ i subunit recycling, and there is little information regarding the potential biological function of the AGS3/G ␣ i -GDP complex. Is the complex a signaling molecule rather than merely inhibiting the G ␣ i signaling? The AGS3/G ␣ i1 -GDP complex has been shown to be in close proximity with Ric-8A, a GEF which facilitates the exchange of GDP to GTP on G ␣ i1 [54] ( fig. 5 ) . Another study has demonstrated that Ric-8A can promote the exchange of GDP for GTP on G ␣ i subunit bound to AGS3 in Caenorhabditis elegans [55] . These observations present a mechanism contrary to the common understanding of AGS3 inhibiting the G ␣ i signaling and enhancing the G ␤ ␥ signaling. Further study is required to understand the characteristics of the AGS3/G ␣ i -GDP complex. Detailed cAMP accumulation assay procedure is described in [110] . * p ! 0.05; * * p ! 0.01. All data presented are representative of three experiments, and individual values were the average of triplicate.
Color version available online The development of addiction requires long-term neuro-adaptations in relevant brain circuits. AGS3 has been described to alter the trafficking of protein [40] , a crucial component of synaptic plasticity, including plasma membrane receptors and channels. The Drosophila melanogaster partner of inscuteable (mPins), an AGS3 homolog, has been reported to enhance trafficking of SAP102 and NMDA receptor to the plasma membrane in neurons [56] . Furthermore, the overexpression of AGS3 in COS7 cells modulates the surface expression level of a set of heterologously expressed plasma membrane receptors and channels with a significant increase in surface expression of inwardly rectifying potassium ion channel subtype Kir2.1 [40] . Identifying plasma membrane receptors or channels regulated by AGS3 in neurons would be one of the key tasks in future studies.
Regulation of Asymmetric Cell Division by AGS3 and AGS5
Asymmetric cell division is a biological process which divides the mother cell into two daughter cells with different cell fates. It involves three main steps: establishment of cell polarity, mitotic spindle orientation, and cell fate determinants segregation, each of which requires tight regulation in order to properly divide the cell asymmetrically. Asymmetric cell division plays an important role in developing brain by regulating neural progenitor cells to produce one daughter cell capable to differentiate into the many cell types of the CNS and another daughter cell for self-renewal. Therefore, significant efforts have been put into the study of mechanisms of asymmetric cell division in the past decade in order to broaden our understanding in brain development and develop therapeutic approaches to target cancer stem cell. To date, abundant literatures indicate that the GPR-containing AGS3 and AGS5 are involved in asymmetric cell division.
AGS5 is a close homologue of AGS3. It contains seven TPR, four GPR domains, and shares 66% homology with AGS3. Like AGS3, AGS5 is a GDI which can bind and stabilize G ␣ i -GDP and dissociate G ␤ ␥ subunits for signaling. AGS5 is also named as Leu-Gly-Asn-enriched protein (LGN) or GPSM2 named by HUGO Gene Nomenclature Committee. Apart from asymmetric cell division, AGS5 plays various roles in multiple biological functions including GIRK channel regulation [57] , mitotic spindle organization [58] [59] [60] , NMDA receptor trafficking [56] and phototransduction [61] .
In Drosophila neuroblasts, a model for studying asymmetric cell division, the establishment of cell polarity along an apical-basal axis is tightly controlled by an evolutionarily conserved Par complex including Bazooka (Baz, a Drosophila homolog of Par3), Par6 and atypical PKC, localized at the apical cortex [62] . The Baz/Par6/ aPKC complex is responsible for establishing cell polarity and subsequently links with another protein complex consisting of Partner of Inscuteable (Pins; a Drosophila homolog of AGS3 and AGS5), Mud (nuclear mitotic apparatus, NuMA, in mammals) and G ␣ i via Inscuteable (Insc) [63] . The Mud/Pins/G ␣ i complex orientates mitotic spindles along the apical-basal axis of the neuroblasts [64, 65] . These complex proteins are evolutionally conserved in mammals and are predicted to provide similar functions in mammalian asymmetric cell division.
Based on our current knowledge of asymmetric cell division obtained from D. melanogaster and C. elegans , it is considered that the evolutionarily conserved mammalian complexes of Par3/Par6/aPKC and NuMA/AGS5/ G ␣ i are physically linked by the adaptor protein mInsc. However, a recent publication shows that the interactions of NuMA and mInsc with AGS5 are mutually exclusive with AGS5 binding to mInsc preferentially [66] . Therefore, it has been suggested that the Baz/Par6/aPKC/Insc complex recruits Pins to the apical cortex at the delamination/late interphase and subsequently free the Pins for forming the Mud/Pins/G ␣ i complex at the prometaphase [66] . This observation renews our understanding of the roles of these two complexes in asymmetric cell division.
Increasing evidence shows that AGS3 is involved in asymmetric cell division. In cerebral cortical progenitor cells from developing mammalian neocortex, AGS3 regulates the apical-basal division and asymmetric cell-fate decisions via G ␤ ␥ subunits [36] . Knock-down of AGS3 shifts the mitotic spindle from the apical-basal axis to the planar axis and leads to failures in proper mitotic spindle orientation and asymmetric cell-fate determination [36] . The impairment of the G ␤ ␥ signaling causes the same defects as AGS3 knock-down, suggesting that AGS3 and the G ␤ ␥ subunits exist in the same pathway and that AGS3 may regulate the G ␤ ␥ signaling via its GDI activity [36] . Moreover, the GPR domains of AGS3 can be phosphorylated by LKB1, a serine/threonine kinase which is involved in the regulation of cell polarity and cell cycle progression [67] . Although the biological significance of AGS3 phosphorylation by LKB1 remains unknown, it seems to diminish GDI activity in vitro [67] . In addition, AGS3 interacts with mammalian Insc (mInsc) and form a complex with Par3 [68, 69] , implying a potential role in the regulation of spindle orientation and cell fate in the developing retina [68] .
AGS5 has been extensively reported to play a key regulatory role in asymmetric cell division by controlling mitotic spindle orientation and organization in the neuroepithelium [59] , epidermis [70] , retina [68] , dermomyotome [71] , and distal epithelium of embryonic lung [72] , as well as controlling meiotic spindle orientation in mouse oocytes [73] . Ectopic expression or knock-down of AGS5 results in disruption of spindle-pole organization, chromosome segregation and cell cycle progression [74, 75] . AGS5 interacts with NuMA via its N-terminal domain [74, 76] and regulates the NuMA dynamics at the mitotic spindle poles [77] . The interaction between AGS5 and NuMa is essential to the assembly and organization of the mitotic spindle during mitosis [74, 76] . In addition, the interaction between AGS5 and G ␣ i leads to a cortical repositioning of the mitotic spindle poles at metaphase closer to the cell cortex [58] .
AGS3 and AGS5 share similar motif structures and both interact with G ␣ i proteins, they nevertheless act differently in different cellular systems. They differ in their tissue distribution pattern, expression profile and subcellular localization. As shown in table 2 , they show similar distribution pattern in the brain [78] , but they are differentially regulated during brain development. Maximum expression of AGS3 occurs on postnatal day 7 and is significantly decreased by day 22 in the brainstem, cerebellum, cortex, hippocampus and midbrain [78] . In contrast, the expression level of AGS5 in the same brain regions, except midbrain, is increased overtime during postnatal days 1-22 [78] . Furthermore, AGS3 and AGS5 appear to have different cell type specificities. AGS3 is primarily expressed in neurons whereas AGS5 is found in neurons, astroglia and microglia [78] . The subcellular localization of AGS3 and AGS5 is found to be different in different cell types [78, 79] . In the progenitor cells, AGS5 shows asymmetric distribution in a cell cycle-dependent manner, while AGS3 has a diffused cytoplasmic distribution [79] . These observations imply that one or more unidentified domains in AGS3 and AGS5 may confer their differential regulations in various cell types and developmental stages. How asymmetric cell division is regulated by AGS3 and AGS5 in mammalian brains remains a major area of investigation. As AGS3 is primarily expressed in neurons with maximum expression level in the brain at postnatal day 7 [78] , it may play a more important role in early brain development for generating cell type diversities.
It has been reported that G ␣ i is responsible for recruiting AGS5 to the cell cortex [60, 76] . However, it seems that the AGS5/G ␣ i interaction does more than just the localization of AGS5. The value of GDI activity of AGS3/5 in asymmetric cell division has been addressed in mammalian cortical progenitor cells where AGS3 is a potential regulator of the G ␤ ␥ signaling in regulating spindle orientation and cell-fate determination [36] . Another function of AGS3/5/G ␣ i -GDP is to act as a substrate of Ric-8A, a GEF which promotes the exchange of GDP for GTP on G ␣ i . It recognizes and interacts with the free G ␣ i -GDP subunit but not with the G ␣ i -GDP/G ␤ ␥ heterotrimeric complex [80] . Ric-8A also catalyzes guanine nucleotide exchange on G ␣ i1 -GDP bound to AGS3 [54] or in the NuMA/AGS5/G ␣ i complex which is responsible for regulating mitotic spindle orientation [60, 81] . The release of G ␣ i -GTP from the NuMA/AGS5/G ␣ i complex leads to the dissociation of NuMA for capturing dynein/dynactin complexes at the cell cortex adjacent to the spindle poles and subsequently tethering microtubules for spindle poles assembly and organization [60] . Further studies are needed to delineate the roles of AGS3/5/G ␣ i -GDP in asymmetric cell division.
Control of Neurite Outgrowth by AGS2 and AGS6
Neurite outgrowth is a tightly regulated function in developing neurons, essential for the formation of axons and dendrites. It involves the change of tubulin and actin cytoskeleton dynamics at the growth cone for elongation and branching of the neurites. A decrease in the number of neurite outgrowths is a hallmark of neuronal diseases such as Alzheimer's disease. Increasing evidence has suggested that AGS2 and AGS6 are involved in the regulation of neurite outgrowth.
AGS2 is a light chain component of the cytoplasmic dynein motor protein complex and is also known as Tcomplex testis-specific protein 1 (Tctex-1) or dynein light chain Tctex-type 1 (DYNLT1). It directly interacts with G ␤ ␥ and activates the G ␤ ␥ -mediated pheromone response pathway in S. cerevisiae [2] . Apart from its function in anterograde and retrograde trafficking [82] , it is involved in a number of diversified biological functions including bone resorption [83] , cilium length control [84] , neurite outgrowth [85] [86] [87] , regulation of the fate of neural progenitors [88] , cortical neurogenesis [89] and Orexin receptor signaling [90] . The protein expression of AGS2 within the CNS ( table 2 ) implicates its involvement in neuronal functions.
A role of AGS2 in neurite outgrowth has been unveiled recently. AGS2 knock-down in hippocampal neurons causes neurite development failure, whereas ectopic expression of AGS2 promotes multiple abnormally long axon-like neurites [85] . The neurite outgrowth is regulated by AGS2 in a dynein-independent manner as demonstrated by AGS2-T94E, a mutant unable to bind dynein intermediate chain and predictably do not incorporate into dynein complex [85] . Neurons ectopically expressing AGS2-T94E appear to have similar axon-like neurites as observed in the wild-type transfectants [85] . This observation has led to the study of subcellular distribution pattern of AGS2 in neurons. It was found that AGS2 can exist in either dynein-associated or dynein-free pool depending on its interaction with G ␤ ␥ , which competes against dynein intermediate chain for AGS2 binding and regulates the dynamics of the dynein-free pool of AGS2 [86] . Inhibition of G ␤ ␥ signaling by ␤ ARK-ct inhibits neurite outgrowth, suggesting that G ␤ ␥ /AGS2 complex is essential for AGS2-mediated neuritogenesis [86] . However, the mechanism underlying the regulation of neurite outgrowth by G ␤ ␥ / AGS2 complex remains unclear. Investigation into the modulation of G ␤ ␥ downstream signaling by AGS2 may further reveal the mechanism underlying the control of neurite outgrowth. In addition, the opposite roles of Rac1 and RhoA on promoting and inhibiting neurite outgrowth [91] , respectively, are regulated by AGS2 [85, 87] .
AGS6, also known as RGS12, is a multidomain protein which contains functionally diverse domains including GPR, PDZ, PTB domain, regulator of G protein signaling (RGS) domain and Ras binding domain (RBD). AGS6 may act as a GDI or a GTPase-activating protein (GAP) due to the existence of the GPR and RGS domains, respectively. AGS6 has widespread expression in the CNS ( table 2 ) . It has been reported that AGS6 is involved in neuronal differentiation [92] , terminal differentiation of osteoclasts [93] , regulation of calcium channels [94, 95] , PDGF ␤ receptor signaling [96] and Ras signaling [92] . Recently, it has been demonstrated that AGS6 is involved in regulating neurite outgrowth [92] . Knock-down of AGS6 in PC12 cells as well as dorsal root ganglia neurons inhibits the nerve growth factor-mediated neuritogenesis via a Ras-dependent signal [92] .
Conclusion
AGS proteins have been intensively studied in the past decade and a number of neuronal functions have been demonstrated to be regulated by them. A pressing question is how AGS proteins achieve so many regulatory roles in the CNS? This is probably achieved by specific cellular proteome in each distinct brain region leading to different regulations by the AGS proteins. The different effects of AGS1 on circadian rhythm at different ZTs are examples of how protein expression patterns trigger distinct functional roles. Asymmetric cell division and neuritogenesis are major events in brain development; it has been suggested that AGS proteins may play important regulatory roles during brain development. Therefore, it is of particular interest to extend the studies of AGS proteins in neurogenesis. Moreover, despite the demonstration that AGS proteins can activate the S. cerevisiae pheromone response pathway in the absence of a pheromoneresponsive GPCR, the precise mechanism by which AGS proteins modulate G protein signaling in mammalian cells remain poorly defined. The ability of AGS proteins to elicit G ␤ ␥ -dependent signaling is mostly inferred from its binding preference for GDP-bound G ␣ i subunits. As illustrated by their participation in complex adaptive responses such as drug addiction, the AGS proteins are likely to affect more than just the G ␤ ␥ signaling pathway. A thorough understanding of how the expression and localization of AGS proteins are regulated in neurons will help to discern their function in our CNS. The delineation of the mechanisms underlying each AGS-mediated neuronal function in mammalian system will be extremely challenging.
